Heart Disease Clinical Trials in Ohio

Showing 141-160 of 458 trials

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

NCT00826280

Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI

Coronary Artery Disease (CAD)

Astellas Pharma Inc347 participantsStarted Mar 2009

Birmingham, Alabama, United States • Huntsville, Alabama, United States • La Mesa, California, United States +22 more locations

COMPLETED32 miles

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

NCT02178943

Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.

Cardiac Transplant FailureCardiac Transplant RejectionHeart Diseases

CareDx100 participantsStarted Jun 2014

Beverly Hills, California, United States • Los Angeles, California, United States • Stanford, California, United States +25 more locations

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Heart Disease Trials in Other Cities

REmodeling the Left Ventricle With Atrial Modulated Pacing

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Benefits of µCor in Ambulatory Decompensated Heart Failure

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

Physiologic Pacing Registry

Acorai Machine Learning Generalization (MLG) Study

Breethe Abiomed Recovery RegisTry (BART)

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

Other Conditions in Ohio